Figure 1.
Study design ascertaining outcomes from three rounds of screens based on the temporal natural history of breast cancer. BC, breast cancer; Ki-67, Ki-67 proliferation; HER-2/neu, HER-2/neu immunohistochemistry score.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.